Literature DB >> 8923474

Metabolism of (-)-deprenyl and PF-(-)-deprenyl in brain after central and peripheral administration.

A Lajtha1, H Sershen, T Cooper, A Hashim, J Gaál.   

Abstract

We examined the cerebral metabolism of L-deprenyl and its fluoro-derivative pF-deprenyl, assaying the parent compounds, their metabolites desmethyl deprenyl, L-amphetamine, and L-methamphetamine, and the fluoro analogs of these metabolites. We compared the levels of the metabolites after subcutaneous injection with those after intracerebral administration (via microdialysis) of the parent compounds. The assay of the parent compounds and their metabolites was by GC-MS measurement of the components of brain microdialysate samples. After their subcutaneous administration, deprenyl and F-deprenyl rapidly entered the brain and then their concentration decreased, with an approximate half-life of 4.5 h. After the intracerebral administration the diffusion from the site of administration was minor. A small fraction (a few percent) of the intracerebrally administered deprenyl was metabolized in situ in the brain possibly by a nonenzymatic process. Metabolism of pF-deprenyl was somewhat more rapid. The higher cerebral levels of metabolites after the subcutaneous administration indicate their exogenous origin-metabolism of parent compounds in the periphery and penetration of the brain by the metabolites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923474     DOI: 10.1007/bf02532389

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  13 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

Review 2.  Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.

Authors:  I Sziráki; V Kardos; M Patthy; M Pátfalusi; J Gaál; M Solti; E Kollár; J Singer
Journal:  J Neural Transm Suppl       Date:  1994

3.  Deprenyl is metabolized to methamphetamine and amphetamine in man.

Authors:  G P Reynolds; J D Elsworth; K Blau; M Sandler; A J Lees; G M Stern
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

4.  Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry.

Authors:  M L Reimer; O A Mamer; A P Zavitsanos; A W Siddiqui; D Dadgar
Journal:  Biol Mass Spectrom       Date:  1993-04

5.  Deprenyl reduces the death of motoneurons caused by axotomy.

Authors:  P T Salo; W G Tatton
Journal:  J Neurosci Res       Date:  1992-02       Impact factor: 4.164

6.  (-)-Deprenyl alters the survival of adult murine facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants.

Authors:  C Oh; B Murray; N Bhattacharya; D Holland; W G Tatton
Journal:  J Neurosci Res       Date:  1994-05-01       Impact factor: 4.164

7.  (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis.

Authors:  W G Tatton; W Y Ju; D P Holland; C Tai; M Kwan
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

Review 8.  Behaviour of (-)-deprenyl and its analogues.

Authors:  K Magyar
Journal:  J Neural Transm Suppl       Date:  1994

Review 9.  Levodopa therapeutics: new treatment strategies.

Authors:  P A LeWitt
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

10.  Methamphetamine protects against MPTP neurotoxicity in C57BL mice.

Authors:  I Sziráki; V Kardos; M Patthy; M Pátfalusi; G Budai
Journal:  Eur J Pharmacol       Date:  1994-01-14       Impact factor: 4.432

View more
  5 in total

1.  A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.

Authors:  Sevil Yasar; József Gaál; Leigh V Panlilio; Zuzana Justinova; Szecsö V Molnár; Godfrey H Redhi; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

2.  Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.

Authors:  Sevil Yasar; Jozsef Gaal; Zuzana Justinova; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Authors:  Michael B Gatch; Cynthia M Taylor; Elva Flores; Meghan Selvig; Michael J Forster
Journal:  Behav Pharmacol       Date:  2006-03       Impact factor: 2.293

Review 4.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

5.  Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2006-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.